Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).

Source:http://linkedlifedata.com/resource/pubmed/id/20644101

J. Clin. Oncol. 2010 Oct 20 28 30 4630-4

Download in:

View as

Triples

General Info

PMID
20644101